These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
70 related items for PubMed ID: 1558317
1. Failure to demonstrate beneficial effect of prostacyclin (PGI2) infusion on red blood cell deformability in patients with peripheral vascular disease: a possible role of the leukocytes. Parise P, Berrettini M, Grasselli S, de Cunto M, Nenci GG. Angiology; 1992 Apr; 43(4):320-7. PubMed ID: 1558317 [Abstract] [Full Text] [Related]
3. Intravenous prostacyclin (PGI2) infusion to 108 patients with ischaemic peripheral vascular disease: phase II-open study. Virgolini I, Fitscha P, Weiss K, Linet OI, O'Grady J, Sinzinger H. Prostaglandins; 1991 Jul; 42(1):9-14. PubMed ID: 1771241 [Abstract] [Full Text] [Related]
4. Prostacyclin increases filterability of normal and rigidified human red blood cells in vitro. Kovacs IB, O'Grady J. Agents Actions; 1984 Feb; 14(2):306-10. PubMed ID: 6424425 [Abstract] [Full Text] [Related]
5. Lack of effect of pentoxifylline on red blood cell deformability. Cummings DM, Ballas SK, Ellison MJ. J Clin Pharmacol; 1992 Nov; 32(11):1050-3. PubMed ID: 1474167 [Abstract] [Full Text] [Related]
6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities]. Maksimović ZV. Srp Arh Celok Lek; 1999 Nov; 127(7-8):249-53. PubMed ID: 10624398 [Abstract] [Full Text] [Related]
10. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with peripheral arterial disease. Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Wien Klin Wochenschr; 1993 Nov; 105(1):7-11. PubMed ID: 8438599 [Abstract] [Full Text] [Related]
11. Preliminary experience with prostaglandins E1 and I2 in peripheral vascular disease. Pardy BJ, Lewis JD, Eastcott HH. Surgery; 1980 Dec; 88(6):826-32. PubMed ID: 7003784 [Abstract] [Full Text] [Related]
13. The effect of prostacyclin and nitric oxide on deformability of red blood cells in septic shock in rats. Korbut R, Gryglewski RJ. J Physiol Pharmacol; 1996 Dec; 47(4):591-9. PubMed ID: 9116326 [Abstract] [Full Text] [Related]
18. Effects of tolazoline and prostacyclin on pulmonary hypertension in infants after cardiac surgery. Schranz D, Zepp F, Iversen S, Wippermann C, Huth R, Zimmer B, Jüngst BK, Oelert H. Crit Care Med; 1992 Sep; 20(9):1243-9. PubMed ID: 1521438 [Abstract] [Full Text] [Related]
19. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication. Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E. Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196 [Abstract] [Full Text] [Related]
20. Increased prostacyclin metabolites and decreased red cell deformability in patients with systemic sclerosis and Raynauds syndrome. Belch JJ, McLaren M, Anderson J, Lowe GD, Sturrock RD, Capell HA, Forbes CD. Prostaglandins Leukot Med; 1985 Jan; 17(1):1-9. PubMed ID: 3883365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]